期刊文献+

奥司他韦(达菲)治疗流感样症状病例的疗效分析 被引量:5

Oseltamivir(dafei) treatment of influenza symptoms of samples efficacy analysis
下载PDF
导出
摘要 目的观察磷酸奥司他韦治疗流感样症状患者的疗效。方法47例流感样症状患者的病例,随机分成两组,治疗组22例,磷酸奥司他韦75 mg,每日2次口服,疗程5 d;对照组25例,常规流感对症治疗(感冒灵冲剂),疗程5-7 d。结果治疗组发热持续时间较对照组平均缩短24 h,其他流感样症状治疗组比对照组平均缩短21 h。结论奥司他韦作为抗流感病毒药物治疗流感样症状患者安全有效。 Aim To observe,oseltamivir phosphate treatment of Influenza symptoms samples efficacy.Methods 47 patients with suspected cases ofInfluenza symptoms samples were randomly divided into two groups,treatment group,22 cases,oseltamivir phosphate 75 mg,2 times a day orally,time of treatment 5 days;control group,25 cases,conventional symptomatic treatment of influenza(flu Chongji),treatment 5~7 d.Results The duration of fever treatment group compared with the control group reduced their average 24 h,other influenza-like symptoms,the treatment group compared with the control group reduced their average 21 h.Conclusion oseltamivir,as anti-influenza virus drug treatment of Influenza symptoms samples safe and effective.
作者 王业满
出处 《安徽医药》 CAS 2010年第7期835-836,共2页 Anhui Medical and Pharmaceutical Journal
关键词 流感样症状患者 奥司他韦 疗效分析 influenza symptoms samples oseltamivir efficacy analysis
  • 相关文献

参考文献6

二级参考文献26

  • 1Kim CU, Lew W, Williams MA, et al. Influenza neuraminidasc inhibitors possessing a novel hydrophobic interaction in the enzyme active site. J Am Chem Soc, 1997,119:681-690.
  • 2Hayden FG, Treanor J J, Fritz RS, et al. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza:randomized eontrolled trials for prevention and treatment. JAMA,1999,282 : 1240 -1246.
  • 3Hayden FG, Atmar RL, Schilling M, et al. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. N Engl J Med, 1999,341 : 1336-1343.
  • 4Treanor JJ, Hayden FG, Vrooman PS, et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group. JAMA, 2000, 283:1016-1024.
  • 5Nicholson KG, Aoki FY, Osterhaus AD, et al. Efficicy and safety of oseltamivir in treatment of acute influenza: a randomized controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group. Lancet, 2000,355:1845-1850.
  • 6Monto AS, Fleming DM, Henry D, et al. Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections. J Infect Dis, 1999,180:254-261.
  • 7Hayden FG,Hay AJ. Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine. Curr Top Microbiol Immunol,1992,176:119-130.
  • 8Whitley RJ,Hayden FG,Reisinger KS,et al. Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J,2001,20:127-133.
  • 9Upshur RE,Knight K,Goel V. Time-series analysis of the relation between influenza virus and hospital admissions of the elderly in Ontario,Canada,for pneumonia,chronic lung disease,and congestive heart failure. Am J Epidemiol,1999,149:85-92.
  • 10Narukawa M,K Minezaki K,Okubo M,et al. Impact of an influenza pandemic on the mortality of congestive heart failure in older Japanese:the 1998 Japanese influenza pandemic. J Am Geriatr Soc,2001,49:689-690.

共引文献122

同被引文献34

引证文献5

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部